FEATURE ARTICLES
Eli Lilly and Company's one-team mindset aims to templatize facility design while remaining nimble enough to react to new manufacturing breakthroughs.
- How To Implement Post-Approval Changes On A Global Level
- March 2026 — CDMO Opportunities And Threats Report
- From Principles To Practice: Building Quality Into Generative AI-Assisted Pharma Operations
- Lilly's Toolbox For Fast Track Fill Finish Sites
- From QM To QMM For AI-Assisted Pharmaceutical Manufacturing Operations
- 4 Facility Considerations for API Manufacturing
- Ever Wonder What Running A $50B Capital Facilities Project Feels Like?
PHARMA ONLINE WHITE PAPERS
-
![GettyImages-2036497698 clinical lab]( "Molecular Properties Of PROTACs And The Relationship To Formulation Design")
Molecular Properties Of PROTACs And The Relationship To Formulation DesignHere, we conduct a comprehensive analysis of diverse PROTAC (Proteolysis Targeting Chimeras) structures, evaluating their calculated physicochemical properties to identify key trends.
-
Viral Disinfectant Efficacy Studies: Key Guiding Factors And Design Elements4/8/2025
Achieving compliance and safety through Disinfectant Efficacy Studies (DES) is about adhering to regulations and committing to high standards of safety and quality of manufacturing operations.
-
Open-Label Study Assessing Relative And Absolute Bioavailability1/26/2026
Consistent absorption across different formulations and dietary conditions ensures stable therapeutic exposure. This flexibility simplifies patient dosing schedules and supports manufacturing transitions.
-
The Benefits Of Incorporating Lean Methodologies Into Project Management8/20/2024
Delve into the core principles of lean project management and explore how these principles can be integrated with traditional methods to enhance project outcomes.
-
Facilitate Handling Of Bulk Powders With Dry Granulation8/11/2025
Handling bulk powders in manufacturing presents serious challenges—from unpredictable caking to safety risks—that can disrupt workflows. Discover solutions to streamline operations and protect your team.
-
EMA Support For Rare Disease Therapies6/10/2025
Review how the EMA supports rare disease drug development through regulatory and financial incentives for therapies that meet strict eligibility and ongoing compliance criteria.
PHARMA ONLINE APP NOTES & CASE STUDIES
- AI Predictive Maintenance Prevents Batch Loss And Production Shutdown
- LC-UV-Based Synthetic Peptide Impurity Tracking And Reporting
- Assessment Of Compound Toxicity Effects With High-Content Imaging
- PPQ: Early Adoption Of Digital Process Systems Puts You In Control
- Prevent The Risk Of Cross-Contamination With Microbial Colony Pickers
NEWSLETTER ARCHIVE
- 04.18.26 -- Quality Assurance Product Showcase
- 04.17.26 -- De-Risk Your Small Molecule Program
- 04.16.26 -- From Principles To Practice: Building Quality Into Generative AI-Assisted Pharma Operations
- 04.16.26 -- STREAM Edition: Batch Vs. Continuous Process Evolution
- 04.15.26 -- Innovation That's Redefining Aseptic Filling
INDUSTRY NEWS
-
![FDA Logo on phone screen-GettyImages-2208861549]( "Høeg In, Pazdur Out At The FDA")
Høeg In, Pazdur Out At The FDAWhat an eventful week it has been at the FDA, with Richard Pazdur, M.D., resigning after weeks in his position as director of Center for Drug Research and Evaluation (CDER), and his vacancy being quickly filled by acting director Tracy Beth Høeg, M.D.
-
![business peope negotiating-GettyImages-637902194]( "9 Drugs Granted Fast Track By FDA's Voucher Program")
9 Drugs Granted Fast Track By FDA's Voucher ProgramWith targets like pancreatic cancer, deafness, blindness, infertility and vaping addiction, these drugs were chosen due to an unmet need, addressing a public health crisis, boosting domestic manufacturing or increasing affordability.
-
![Pharmaceutical sorting machine, pills-GettyImages-1499814881]( "Leaders In The Excipient Market: Region And Type")
Leaders In The Excipient Market: Region And TypeThough North America led the market with a 38.32% market share of $3.15 billion in 2024, Asia Pacific is expected to have the fastest growth in the upcoming years.
-
![GettyImages-2189405678-GLP-1-obesity]( "Pfizer Strengthens Obesity Foothold With Metsera Acquisition")
Pfizer Strengthens Obesity Foothold With Metsera AcquisitionAfter discouraging efforts to bring two oral obesity drugs to market—danuglipron and lotiglipron—this acquisition launches Pfizer back into the obesity therapeutic game.
-
![weight loss, diabetes, insulin pen-GettyImages-2196049931]( "FDA Cracks Down On GLP-1 Imports")
FDA Cracks Down On GLP-1 ImportsGLP-1 bulk drug substances must be detained without physical examination (DWPE) unless they are on a list (Green List) of approved foreign GLP-1 manufacturers.
PHARMACEUTICAL ONLINE CONTENT COLLECTIONS
Explore how sterility assurance, including sterilization validation and environmental monitoring, is essential for controlling microbial contamination in mammalian cell production to ensure patient safety. Check out the latest e-book from Pharmaceutical Online.
More Content CollectionsSUPPLIER NEWS
-
Antares Vision Group To Present Denester-Inspection-Labeling Line For Prefilled Syringes At INTERPHEX 2026 Conference4/17/2026
Antares Vision Group will offer live demonstrations of an integrated line providing automatic denesting, inspection and labeling for prefilled syringe production at Interphex Booth 2821.
-
Flow Sciences Appoints Kent Lupino As Chief Marketing Officer4/14/2026
Flow Sciences, Inc., a global leader in advanced containment solutions for laboratory and pharmaceutical environments, today announced the appointment of Kent Lupino as chief marketing officer. Lupino will be based at the company's new office in North Carolina's Research Triangle Park (RTP) and will report directly to Chief Executive Officer Jonathan Mann.
-
Groninger To Debut "Lifecycle Solutions" At INTERPHEX 20264/14/2026
At the show, groninger USA will debut its newly launched service concept, “Lifecycle Solutions.” The program consolidates all services across the entire lifecycle of the company’s machines – from commissioning and continuous optimization to modernization and retrofit. In doing so, it reflects the company’s ongoing commitment to service, quality, and providing long-term solutions availability.
